Defunct Company
Total Trials
50
As Lead Sponsor
4
As Collaborator
46
Total Enrollment
985,530
NCT00209534
A Study of AQUAVAN® Injection in the Presence of Pre-Medication in Patients Undergoing Elective Colonoscopy
Phase: Phase 2
Role: Collaborator
Start: Jan 31, 2003
Completion: Feb 29, 2004
NCT00209573
A Study of AQUAVAN® Injection Versus Midazolam HCl for Sedation in Patients Undergoing Elective Colonoscopy
Phase: Phase 3
Start: Sep 30, 2004
Completion: Dec 31, 2004
NCT00356174
An Observational Study of Childhood Food Allergy
Phase: N/A
Start: Jul 31, 2006
Completion: Aug 31, 2016
NCT00461097
Oral Immunotherapy for Childhood Egg Allergy
Start: May 31, 2007
Completion: Dec 31, 2013
NCT00580606
A Randomized, Double-Blind Placebo-Controlled Peanut Sublingual Immunotherapy Trial
Phase: Phase 1/2
Start: Dec 31, 2007
Completion: Dec 31, 2014
NCT00789880
Analysis of Response of Subjects With Atopic Dermatitis or Psoriasis to Oral Vitamin D3
Start: Dec 31, 2008
Completion: Dec 31, 2009
NCT00850668
Peanut Allergy Vaccine Study in Healthy and Peanut-allergic Adults
Phase: Phase 1
Start: Oct 31, 2009
Completion: Oct 31, 2010
NCT01018225
Exploratory Study Evaluating the Effects of Darifenacin on Nocturia, Sleep and Daytime Wakefulness
Phase: Phase 4
Role: Lead Sponsor
Start: Nov 30, 2009
Completion: Jul 31, 2010
NCT01235260
Becaplermin Use and Cancer Risk in a Patient Population of U.S. Veterans With Diabetes
Start: Mar 31, 2010
Completion: Mar 31, 2011
NCT01544816
Evaluating the Effects of Snack Products on Energy
Start: Feb 29, 2012
Completion: Aug 31, 2012
NCT01625624
Evaluating the Effects of Food Products on Energy and Performance
Start: Jun 30, 2012
Completion: Jun 30, 2012
NCT03950180
Assessing The Impact Of Incorporating Charlson Comorbidity Scores On Patient Anxiety And Satisfaction
Start: Jul 12, 2013
Completion: Feb 27, 2015
NCT01846208
Baked Egg or Egg Oral Immunotherapy for Children With Egg Allergy
Start: Jul 31, 2013
Completion: Sep 30, 2018
NCT01904604
Peanut Epicutaneous Phase II Immunotherapy Clinical Trial
Start: Sep 30, 2013
Completion: Aug 21, 2018
NCT02213341
Impact of Vaccination on Th2 Immunity in Infancy
Start: Jan 31, 2015
Completion: Jun 14, 2016
NCT02561897
EdoxabaN or Warfarin Therapy In Device Procedures in Patients With Non-Valvular Atrial Fibrillation
Start: Dec 31, 2015
Completion: Dec 31, 2017
NCT02623660
Microcurrent Stimulation Reduces Post-Operative Swelling and Healing Time Following Knee Replacement Surgery
Start: Jan 31, 2016
Completion: Oct 31, 2016
NCT02775955
PK Study of Intranasal RX0041-002 in Subjects With Severe Renal Impairment and Normal Renal Function
Start: Feb 29, 2016
NCT02775981
Pharmacokinetic Study of Intranasal RX0041-002 in Hepatic-Impaired Individuals and Subjects With Normal Hepatic Function
Completion: Sep 30, 2016
NCT03710252
A Study to Investigate HCV Response Rates in Real World Patients: HEARTLAND Study
Start: Mar 31, 2016
Completion: Sep 30, 2017
NCT02959073
Evaluation of a New Self-assessed, Home-based Symptom Score in Cat Allergic Patients
Start: Sep 30, 2016
Completion: Feb 28, 2017
NCT03012334
The Effects of Lasmiditan on Simulated Driving Performance - Healthy Participants
Start: Jan 16, 2017
Completion: Jun 8, 2017
NCT02750904
Web-Delivered Acceptance & Commitment Therapy for Smokers With Bipolar Disorder
Start: Apr 3, 2017
Completion: May 14, 2019
NCT03353922
Driving Simulation to Assess Non-Sedative Effects of Tolperisone
Start: Jul 31, 2017
Completion: Jan 30, 2018
NCT03520517
Open-label Study to Evaluate Safety, Tolerability and PK of BHV-0223 in ALS
Start: Feb 2, 2018
Completion: Oct 8, 2018
NCT03414801
Red Maple Trials Cat Allergen Natural Exposure Chamber Validation in Cat-allergic Subjects
Start: Feb 6, 2018
Completion: Jul 30, 2018
NCT04010305
Sub-Lingual Dexmedetomidine in Agitation Associated With Schizophrenia
Start: May 22, 2019
Completion: Jul 31, 2019
NCT04158687
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-692 as an Adjunctive Treatment in Adults With Schizophrenia
Start: Nov 26, 2019
Completion: Dec 22, 2020
NCT04251910
Sub-Lingual Dexmedetomidine in Agitation Associated With Dementia
Start: Dec 27, 2019
Completion: Jan 24, 2022
NCT04268303
Dexmedetomidine in the Treatment of Agitation Associated With Schizophrenia
Start: Jan 24, 2020
Completion: May 6, 2020
NCT04276883
Dexmedetomidine in the Treatment of Agitation Associated With Bipolar Disorder
Start: Feb 24, 2020
Completion: May 21, 2020
NCT04470050
Dexmedetomidine in the Treatment of Symptoms Of Acute Opioid Withdrawal
Start: Jun 9, 2020
Completion: Feb 18, 2021
NCT04838795
Sisonke (Together): OPEN LABEL TRIAL COVID-19
Start: Feb 17, 2021
Completion: Mar 31, 2022
NCT05313386
Study of BXCL501 In Agitation Associated With Delirium in ICU Patients
Start: Feb 23, 2021
Completion: Feb 21, 2022
NCT04798079
Systems Biology of Early Atopy
Start: Mar 18, 2021
Completion: Mar 31, 2032
NCT04793698
Multisite Feasibility of Compassion Meditation for Veterans With Posttraumatic Stress Disorder (PTSD)
Start: May 6, 2021
Completion: Sep 30, 2026
NCT03564548
Inhaled Cannabinoids Versus Immediate-release Oral Opioids for the Management of Breakthrough Cancer Pain
Start: May 26, 2021
Completion: Apr 30, 2022
NCT04778176
Assessing the Pharmacokinetics, Safety, Tolerability and Efficacy of Continuous Oral Levodopa Via the DopaFuse® Delivery System in Parkinson's Disease Patients
Start: Jun 16, 2021
Completion: Aug 2, 2022
NCT04970342
Validation of the Drug Impaired Driving Scenario (DIDS) on the CRCDS-miniSim
Start: Jul 16, 2021
Completion: Aug 21, 2021
NCT05025605
Determining Efficacy and Safety of BXCL501 in Agitation Associated With Pediatric Schizophrenia and Bipolar Disorder
Start: Aug 27, 2021
Completion: Dec 31, 2026
NCT05148845
Sisonke 2 - A COVID-19 Vaccine Boost Open Label Study.
Start: Nov 10, 2021
Completion: Jun 30, 2023
NCT05071430
Safety and Efficacy of HB-1 for Panic Disorder
Start: Feb 3, 2022
Completion: Dec 12, 2022
NCT05276830
An Efficacy, and Safety Study Of BXCL501 For The Treatment Of Agitation Associated With Dementia
Start: Feb 8, 2022
Completion: Apr 1, 2022
NCT05271552
Dexmedetomidine in the Treatment of Agitation Associated With Dementia (TRANQUILITY II)
Start: Apr 27, 2022
Completion: Apr 21, 2023
NCT05436067
Individualized Vestibular Rehabilitation for Elderly With Self-Management and Gaming Elements
Start: May 23, 2022
Completion: Jan 13, 2023
NCT05665088
Dexmedetomidine in the Treatment of Agitation Associated With Dementia (TRANQUILITY III)
Start: Dec 14, 2022
Completion: Sep 11, 2023
NCT05547503
Phase I Single Ascending Dose and Multiple Ascending Doses of Oral AFA-281 in Healthy Volunteers
Start: Apr 11, 2023
Completion: May 14, 2025
NCT06245213
A Study of ANAVEX3-71 in Adults With Schizophrenia
Start: Mar 15, 2024
Completion: Jun 30, 2025
NCT06216132
Study of the BIOPIN 6 Naltrexone Implant in Healthy Adults
Start: Jun 24, 2024
Completion: Apr 25, 2025
NCT06417762
Dime La VerDAD: Verify, Debunk, and Disseminate
Start: Jul 2, 2024
Completion: Apr 1, 2028